VAERS reports by lot

GSK Varicella/Shingles lot 44T97: VAERS reports

41 VAERS reports list lot 44T97 as a GSK Varicella/Shingles vaccine, received between 2022-09-22 and 2024-05-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
41
Reports
2%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1334%
General / Systemic (non-local)1026%
Neurological513%
Dermatological (non-injection-site)411%
Allergic / Anaphylactic38%
Musculoskeletal25%
Cardiac / Cardiovascular13%

Where reports came from

U.S. state of the reporter, where given (top 9).

District of Columbia24
New York3
Massachusetts2
Pennsylvania2
Maryland1
Wisconsin1
Minnesota1
Michigan1
Connecticut1

Reports by month received

2022-092
2022-104
2022-113
2022-121
2023-011
2023-071
2023-128
2024-019
2024-024
2024-033
2024-042
2024-053

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.